BioVoice News December 2017-January 2018 Issue 7 Volume 2 | Page 35

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: Our customer solutions are powered by the IQVIA CORE. The CORE enables us to provide customized solutions for customers, leveraging the world’s largest curated healthcare information source, advanced analytics, leading technologies and extensive industry knowledge across diseases, geographies, and scientific methods. knowledge across diseases, geographies, and scientific methods. It fuels the company’s approach to human data science, including faster, more predicable clinical development, innovative approaches to generating real- world evidence, machine learning to improve patient care, and strategies for precision commercial engagement. The seamless integration of these elements from molecule to market bio chat consistently evaluate our resource needs and makes adjustments in line with our strategy and business requirements to best meet the needs of all our stakeholders - including customers and patients. Since the merger, we’ve worked to integrate our capabilities in advanced analytics, leading technologies and therapeutic Will IQVIA also expertise into invest in the powerful, expansion in terms differentiated of infrastructure offerings. Our vision in and human India, as across the resources? What is globe, is to outpace the the company's inevitable progress of immediate list of change across the life sciences and accelerate activities and our ability to empower priorities in the healthcare decision Indian context? makers to meet the We routinely and n future head on. enables our customers to drive enhanced value, access and health outcomes around the world. BioVoiceNews.com 35